| P50 | author | P Todd Korthuis | Q114317550 |
| P2093 | author name string | Daniel L Schwartz | |
| | Milky Kohno | |
| | William F Hoffman | |
| | Laura E Dennis | |
| | Holly McCready | |
| P2860 | cites work | The PhenX Toolkit: get the most from your measures | Q24630562 |
| | Neurocircuitry of addiction | Q24647156 |
| | Pharmacotherapy of methamphetamine addiction: an update | Q24648913 |
| | The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. | Q27310644 |
| | Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates | Q28005523 |
| | Improved optimization for the robust and accurate linear registration and motion correction of brain images | Q29547542 |
| | The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 |
| | Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion | Q29619898 |
| | Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. | Q30873118 |
| | Theories of drug craving, ancient and modern | Q31934339 |
| | Pharmacological approaches to methamphetamine dependence: a focused review | Q33906303 |
| | Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. | Q33923752 |
| | Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence | Q33989628 |
| | Endogenous opioid release in the human brain reward system induced by acute amphetamine administration | Q34258315 |
| | Childhood maltreatment and amygdala connectivity in methamphetamine dependence: a pilot study | Q34259281 |
| | Withdrawal symptoms in abstinent methamphetamine‐dependent subjects | Q34767322 |
| | Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients | Q34941455 |
| | A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania | Q34944741 |
| | Brain circuitry and the reinstatement of cocaine-seeking behavior | Q35090481 |
| | Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone | Q35110295 |
| | Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. | Q35205766 |
| | Preclinical and clinical pharmacology of alcohol dependence | Q36709633 |
| | The neurocircuitry of addiction: an overview | Q36741890 |
| | Approaches to the development of medications for the treatment of methamphetamine dependence | Q36817245 |
| | Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people | Q36824245 |
| | Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users | Q37146811 |
| | Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder | Q38867904 |
| | Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals | Q38936254 |
| | Executive Control and Striatal Resting-State Network Interact with Risk Factors to Influence Treatment Outcomes in Alcohol-Use Disorder | Q42367935 |
| | The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans | Q42701015 |
| | A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence | Q42960112 |
| | Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics | Q43714701 |
| | Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions. | Q44341408 |
| | Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation | Q44344394 |
| | Amphetamine induced endogenous opioid release in the human brain detected with [¹¹C]carfentanil PET: replication in an independent cohort | Q44344726 |
| | Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving | Q44349392 |
| | Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. | Q44770090 |
| | Augmentation with naltrexone to treat compulsive sexual behavior: a case series. | Q44804759 |
| | Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics | Q44883777 |
| | Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial. | Q46165138 |
| | Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial | Q46395534 |
| | Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial | Q46423593 |
| | Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. | Q46934801 |
| | Sex differences in young children who meet criteria for attention deficit hyperactivity disorder | Q47567462 |
| | Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study | Q48089647 |
| | Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving | Q48421523 |
| | Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging | Q48448207 |
| | Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. | Q48496653 |
| | Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration | Q48610135 |
| | An open naltrexone treatment study in pathological gambling disorder | Q48664762 |
| | Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis | Q50173946 |
| | The Fifth Edition of the Addiction Severity Index | Q51700999 |
| | Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. | Q52290164 |
| | The relationship between interleukin-6 and functional connectivity in methamphetamine users. | Q52318363 |
| | Naltrexone and Cognitive Behavioral Coping Skills Therapy for the Treatment of Alcohol Drinking and Eating Disorder Features in Alcohol-Dependent Women: A Randomized Controlled Trial | Q59077925 |
| | Binge eating disorder: response to naltrexone | Q72204310 |
| | Injectable extended-release naltrexone for opioid dependence | Q84799498 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toxicology | Q7218 |
| | substance use disorder | Q7632070 |
| | naltrexone | Q409587 |
| | striatum | Q1319792 |
| | pharmacology | Q128406 |
| P304 | page(s) | 186-192 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
| P1476 | title | A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder | |
| P478 | volume | 192 | |